Protein Kinase CK2 and Epstein–Barr Virus
Protein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis, immune response, migration and invasion. In genera...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/358 |
_version_ | 1827758499809984512 |
---|---|
author | Mathias Montenarh Friedrich A. Grässer Claudia Götz |
author_facet | Mathias Montenarh Friedrich A. Grässer Claudia Götz |
author_sort | Mathias Montenarh |
collection | DOAJ |
description | Protein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis, immune response, migration and invasion. In general, viruses use host signaling mechanisms for the replication of their genome as well as for cell transformation leading to cancer. Therefore, it is not surprising that CK2 also plays a role in controlling viral infection and the generation of cancer cells. Epstein–Barr virus (EBV) lytically infects epithelial cells of the oropharynx and B cells. These latently infected B cells subsequently become resting memory B cells when passing the germinal center. Importantly, EBV is responsible for the generation of tumors such as Burkitt’s lymphoma. EBV was one of the first human viruses, which was connected to CK2 in the early nineties of the last century. The present review shows that protein kinase CK2 phosphorylates EBV encoded proteins as well as cellular proteins, which are implicated in the lytic and persistent infection and in EBV-induced neoplastic transformation. EBV-encoded and CK2-phosphorylated proteins together with CK2-phosphorylated cellular signaling proteins have the potential to provide efficient virus replication and cell transformation. Since there are powerful inhibitors known for CK2 kinase activity, CK2 might become an attractive target for the inhibition of EBV replication and cell transformation. |
first_indexed | 2024-03-11T09:07:12Z |
format | Article |
id | doaj.art-ac45635c9f5d4d0caecb368ac4e943cc |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-11T09:07:12Z |
publishDate | 2023-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-ac45635c9f5d4d0caecb368ac4e943cc2023-11-16T19:17:02ZengMDPI AGBiomedicines2227-90592023-01-0111235810.3390/biomedicines11020358Protein Kinase CK2 and Epstein–Barr VirusMathias Montenarh0Friedrich A. Grässer1Claudia Götz2Medical Biochemistry and Molecular Biology, Saarland University, Buildings 44 and 47, 66424 Homburg, GermanyInstitute of Virology, Saarland University, Buildings 44 and 47, 66424 Homburg, GermanyMedical Biochemistry and Molecular Biology, Saarland University, Buildings 44 and 47, 66424 Homburg, GermanyProtein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis, immune response, migration and invasion. In general, viruses use host signaling mechanisms for the replication of their genome as well as for cell transformation leading to cancer. Therefore, it is not surprising that CK2 also plays a role in controlling viral infection and the generation of cancer cells. Epstein–Barr virus (EBV) lytically infects epithelial cells of the oropharynx and B cells. These latently infected B cells subsequently become resting memory B cells when passing the germinal center. Importantly, EBV is responsible for the generation of tumors such as Burkitt’s lymphoma. EBV was one of the first human viruses, which was connected to CK2 in the early nineties of the last century. The present review shows that protein kinase CK2 phosphorylates EBV encoded proteins as well as cellular proteins, which are implicated in the lytic and persistent infection and in EBV-induced neoplastic transformation. EBV-encoded and CK2-phosphorylated proteins together with CK2-phosphorylated cellular signaling proteins have the potential to provide efficient virus replication and cell transformation. Since there are powerful inhibitors known for CK2 kinase activity, CK2 might become an attractive target for the inhibition of EBV replication and cell transformation.https://www.mdpi.com/2227-9059/11/2/358protein kinase CK2phosphorylationEpstein–Barr virusEBV-encoded proteinssignaling pathwaysp53 |
spellingShingle | Mathias Montenarh Friedrich A. Grässer Claudia Götz Protein Kinase CK2 and Epstein–Barr Virus Biomedicines protein kinase CK2 phosphorylation Epstein–Barr virus EBV-encoded proteins signaling pathways p53 |
title | Protein Kinase CK2 and Epstein–Barr Virus |
title_full | Protein Kinase CK2 and Epstein–Barr Virus |
title_fullStr | Protein Kinase CK2 and Epstein–Barr Virus |
title_full_unstemmed | Protein Kinase CK2 and Epstein–Barr Virus |
title_short | Protein Kinase CK2 and Epstein–Barr Virus |
title_sort | protein kinase ck2 and epstein barr virus |
topic | protein kinase CK2 phosphorylation Epstein–Barr virus EBV-encoded proteins signaling pathways p53 |
url | https://www.mdpi.com/2227-9059/11/2/358 |
work_keys_str_mv | AT mathiasmontenarh proteinkinaseck2andepsteinbarrvirus AT friedrichagrasser proteinkinaseck2andepsteinbarrvirus AT claudiagotz proteinkinaseck2andepsteinbarrvirus |